Miplyffa Dosage
Generic name: ARIMOCLOMOL CITRATE 47mg
Dosage form: capsule
Drug class: Miscellaneous metabolic agents
Medically reviewed by Drugs.com. Last updated on Oct 2, 2024.
Recommended Dosage
The recommended oral dosage of MIPLYFFA, in combination with miglustat, for patients with an actual body weight of:
- 8 kg to 15 kg, is 47 mg three times a day
- > 15 kg to 30 kg, is 62 mg three times a day
- > 30 kg to 55 kg, is 93 mg three times a day
- > 55 kg, is 124 mg three times a day
Administer MIPLYFFA with or without food.
Recommended Dosage in Patients with Renal Impairment
The recommended dosage of MIPLYFFA, in combination with miglustat, in patients with an eGFR ≥ 50 mL/minute is the same as the recommended dosage in patients with normal renal function.
For patients with an eGFR ≥ 15 to < 50 mL/minute, the recommended oral dosage of MIPLYFFA, in combination with miglustat, for patients with an actual body weight of :
- 8 kg to 15 kg, is 47 mg two times a day
- > 15 kg to 30 kg, is 62 mg two times a day
- > 30 kg to 55 kg, is 93 mg two times a day
- > 55 kg, is 124 mg two times a day
Administer MIPLYFFA with or without food.
Preparation and Administration Instructions
Swallow MIPLYFFA whole. However, for patients who have difficulty swallowing capsules, administer MIPLYFFA in one of two ways:
Oral Administration
- Carefully open the capsule and sprinkle the entire contents into 15 mL of water or apple juice or 15 mL of soft food (e.g., applesauce, pudding, or yogurt).
- Stir the mixture for 15 seconds.
- Consume the entire mixture immediately.
Feeding Tube Administration (nasogastric or gastric tube)
- Carefully open the capsule and sprinkle the entire contents into 20 mL of water. Do not add the capsule contents to other liquids besides water.
- Stir the mixture for 15 seconds.
- Administer the entire mixture immediately via feeding tube.
- Flush the feeding tube with 5 mL of water after administration.
Do not save the mixture for later use.
More about Miplyffa (arimoclomol)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Professional resources
Related treatment guides
See also:
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Cerdelga
Cerdelga (eliglustat) is used to treat mild to moderate Type 1 Gaucher Disease. Includes Cerdelga ...
Aqneursa
Aqneursa information from Drugs.com, includes Aqneursa side effects, interactions and indications.
Crysvita
Crysvita is used for familial hypophosphatemia, osteomalacia, X-Linked Hypophosphatemia
Galafold
Galafold (migalastat) is used to treat Fabry disease. Includes Galafold side effects, interactions ...
Givlaari
Givlaari injection is used for acute hepatic porphyria (AHP) to reduce the number of acute attacks ...
Iqirvo
Iqirvo (elafibranor) is used to treat primary biliary cholangitis (PBC) in combination with ...
Kuvan
Kuvan is used to help the body activate the enzyme needed to control blood levels of phenylalanine ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.